A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background Guillain-Barré syndrome (GBS) is a rare neurologic disease that occurs at all ages, causing a progressive, ascending paralysis that usually resolves over weeks or months. The disease appears to be identical in children and adults, except that children recover more quickly, with fewer residua. For patients who lose the ability to walk independently, the main treatment options are plasmapheresis or intravenous immune globulin (IVIg), treatments that have shown to have identical effectiveness in adults in two large RCTs involving 388 patients. The effectiveness of the treatments in children has only been studied in small, poorly controlled studies. If one could capture all eligible patients in the United States, only about 100–300 children would be available for a trial annually. Methods The goal of this case was to demonstrate how Bayesian methods could be used to incorporate prior information on treatment efficacy from adults to design a randomized noninferiority trial of IVIg versus plasmapheresis in children. A Bayesian normal–normal model on the hazard ratio of time to independent walking was implemented. Results An evidence-based prior was constructed that was equivalent to 72 children showing exact equivalence between the therapies. A design was constructed based on a Bayesian normal–normal model on the hazard ratio, yielding a sample size of 160 children, with a preposterior analysis demonstrating a “Type I” error rate of 5% and a power of 77%. Conclusions This case study illustrates a rational approach to constructing an evidence-based prior that would allow information from adults to formally augment data from children to minimize unnecessary pediatric experimentation. The frequentist properties of a Bayesian design can be evaluated and reported as they would be for a standard design. Discussion of the appropriate prior for such designs is both a necessary and desirable feature of Bayesian trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Plasmapheresis and acute Guillain‐Barre syndrome
The Guillain-Barré Syndrome Study Group (1985) · Neurology · doi:10.1212/wnl.35.8.1096 · Cited by 773
(1997) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(97)80059-4 · Cited by 610
Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features
Albers, J. W., & Kelly, J. J. (1989) · Muscle & Nerve · doi:10.1002/mus.880120602 · Cited by 346 · cited 1×
“Introduction involves an ascending motor and sensory demyelinating neuropathy that first affects the legs, moving Guillain-Barre syndrome (GBS) is a rare disease, yet upwards until, in the most severe cases, respiratory it is the most common paralytic illness of children, fuLnction can be compromised [2-4].”
BackgroundMcKhann, G. M., Griffin, J. W., Cornblath, D. R., Mellits, E. D., Fisher, R. S., Quaskey, S. A., & The Guillain‐Barré Syndrome Study Group (1988) · Annals of Neurology · doi:10.1002/ana.410230406 · Cited by 275 · cited 1×
“The issue in children is therefore less whether treatment affects long-term prognosis, but rather how it affects the speed of recovery from the clinical nadir [3,6-9].”
BackgroundKleyweg, R. P., & van der Meché, F. G. A. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.11.957 · Cited by 155 · cited 1×
“Introduction involves an ascending motor and sensory demyelinating neuropathy that first affects the legs, moving Guillain-Barre syndrome (GBS) is a rare disease, yet upwards until, in the most severe cases, respiratory it is the most common paralytic illness of children, fuLnction can be compromised [2-4].”
BackgroundGuillain–Barré syndrome in children: Clinical course, electrodiagnosis, and prognosis
Bradshaw, D. Y., & Jones, H. R. (1992) · Muscle & Nerve · doi:10.1002/mus.880150415 · Cited by 148 · cited 3×
“The issue in children is therefore less whether treatment affects long-term prognosis, but rather how it affects the speed of recovery from the clinical nadir [3,6-9].”
BackgroundNatural history and treatment effects in Guillain-Barre syndrome: a multicentre study.
Korinthenberg, R., & Mönting, J. S. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.74.4.281 · Cited by 118 · cited 2×
“The issue in children is therefore less whether treatment affects long-term prognosis, but rather how it affects the speed of recovery from the clinical nadir [3,6-9].”
BackgroundIntravenous Immunoglobulin Treatment in Children with Guillain-Barre Syndrome
Gürses, N., Uysal, S., Çetinkaya, F., Işek, I., & Kalaycı, A. G. (1995) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549509019016 · Cited by 102
The role of plasmapheresis in childhood guillain‐barré syndrome
Epstein, M. A., & Sladky, J. T. (1990) · Annals of Neurology · doi:10.1002/ana.410280112 · Cited by 88 · cited 1×
“Korinthenberg 1996 [9] Paradiso 1999 [19] Epstein 1990 [14] Lamont 1991 [1 3] Graf 1999 [20] 56 40”
Self-citation
Cited by
Summarizing historical information on controls in clinical trials
Neuenschwander, B., Capkun-Niggli, G., Branson, M., & Spiegelhalter, D. J. (2010) · Clinical Trials · doi:10.1177/1740774509356002 · Cited by 396
Bayesian methods for the design and interpretation of clinical trials in very rare diseases
Hampson, L. V., Whitehead, J., Eleftheriou, D., & Brogan, P. A. (2014) · Statistics in Medicine · doi:10.1002/sim.6225 · Cited by 113
“Goodman and Sladky [9] derive an informative prior distribution for a hazard ratio in children by discounting evidence obtained from a meta-analysis of adult trials.”
Bendtsen, M. (2018) · Journal of Medical Internet Research · doi:10.2196/10873 · Cited by 105
“The Bayesian approach taken is not in any sense novel, but has rather been proposed and used before; see Browne et al [13], Goodman and Sladky [14], Krushke [15], Morris et al [16], Spiegelhalter et al [17], and Wijeysundera et al [18].”
MethodGamalo, M., Savić, J., Basu, C., Zhao, X., Gopalakrishnan, M., Gao, A., Song, G., Baygani, S., Thompson, L., Xia, H. A., et al. (2017) · Pharmaceutical Statistics · doi:10.1002/pst.1807 · Cited by 92
Predictively consistent prior effective sample sizes
Neuenschwander, B. E., Weber, S., Schmidli, H., & O’Hagan, A. (2020) · Biometrics · doi:10.1111/biom.13252 · Cited by 105
“In addition to the above example, applications include medical device trials (FDA (2010)), non-inferiority trials with historical or even concurrent placebo (FDA (2010)), pediatric trials with adult data (FDA (2004), Goodman and Sladky (2005)), health-technology assessments (Dias, Welton, Sutton, Ades (2011), Spiegelh…”
BackgroundInfluential
Metadata
- Authors
- Goodman, S. N., & Sladky, J. T.
- Affiliations
- Johns Hopkins University (US)
- Emory University (US)
- ORCID
- Goodman, Steven N
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2005-08
- Volume
- 2
- Issue
- 4
- Pages
- 305-310
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2055605178
- Cited by
- 50
- References
- 19
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 3 · 2018: 8 · 2017: 5 · 2016: 8 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 4
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Clinical Trials (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- Guillain-Barré syndrome, pediatric clinical trials, plasmapheresis, intravenous immunoglobulin, hazard ratio, trial design, sample size determination, preposterior analysis
- MeSH terms
- Adult, Bayes Theorem, Child, Humans, Plasmapheresis, Randomized Controlled Trials as Topic, Walking, Immunoglobulins, Intravenous, Treatment Outcome, Evidence-Based Medicine, Guillain-Barre Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre. https://app.cochat.ai/papers/10.1191/1740774505cn102oa
- The paper
- Goodman, S. N., & Sladky, J. T. (2005). A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre. Clinical Trials. https://doi.org/10.1191/1740774505cn102oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.